BACKGROUND: Findings from previous studies of cutaneous human papillomavirus (cuHPV) infection and keratinocyte carcinomas have varied due to several factors, including use of different sample types for cuHPV DNA detection. Elucidating the relationship between cuHPV infection in eyebrow hairs (EBHs) and skin swabs (SSWs) is critical for advancing the design of future studies. METHODS: DNA corresponding to 46 β-HPV and 52 γ-HPV types was measured in EBHs and SSWs obtained from 370 individuals undergoing routine skin cancer screening examinations. RESULTS: Prevalence of β-HPV/γ-HPV was 92%/84% and 73%/43% in SSWs and EBHs, respectively, with 71%/39% of patients testing positive for β-HPV/γ-HPV in both sample types. Number of cuHPV types detected and degree of infection were correlated across SSWs and EBHs. When the EBH was positive for a given β-HPV/γ-HPV type, the SSW was positive for that same type 81%/72% of the time. CONCLUSIONS: Testing SSWs captures more cuHPV infection than EBHs, with EBH infections usually representing a subset of SSW infections. The importance of optimizing sensitivity of cuHPV infection detection using SSWs vs specificity using EBHs (or a combination of the 2) will be ascertained in an ongoing cohort study investigating cuHPV associations with subsequent keratinocyte carcinomas.
BACKGROUND: Findings from previous studies of cutaneous human papillomavirus (cuHPV) infection and keratinocyte carcinomas have varied due to several factors, including use of different sample types for cuHPV DNA detection. Elucidating the relationship between cuHPV infection in eyebrow hairs (EBHs) and skin swabs (SSWs) is critical for advancing the design of future studies. METHODS: DNA corresponding to 46 β-HPV and 52 γ-HPV types was measured in EBHs and SSWs obtained from 370 individuals undergoing routine skin cancer screening examinations. RESULTS: Prevalence of β-HPV/γ-HPV was 92%/84% and 73%/43% in SSWs and EBHs, respectively, with 71%/39% of patients testing positive for β-HPV/γ-HPV in both sample types. Number of cuHPV types detected and degree of infection were correlated across SSWs and EBHs. When the EBH was positive for a given β-HPV/γ-HPV type, the SSW was positive for that same type 81%/72% of the time. CONCLUSIONS: Testing SSWs captures more cuHPV infection than EBHs, with EBH infections usually representing a subset of SSW infections. The importance of optimizing sensitivity of cuHPV infection detection using SSWs vs specificity using EBHs (or a combination of the 2) will be ascertained in an ongoing cohort study investigating cuHPV associations with subsequent keratinocyte carcinomas.
Authors: Roland Houben; Masahiro Shuda; Rita Weinkam; David Schrama; Huichen Feng; Yuan Chang; Patrick S Moore; Jürgen C Becker Journal: J Virol Date: 2010-05-05 Impact factor: 5.103
Authors: Linda Struijk; Lisa Hall; Els van der Meijden; Patrick Wanningen; Jan Nico Bouwes Bavinck; Rachel Neale; Adèle C Green; Jan Ter Schegget; Mariet C W Feltkamp Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-03 Impact factor: 4.254
Authors: Margaret R Karagas; Heather H Nelson; Peter Sehr; Tim Waterboer; Therese A Stukel; Angeline Andrew; Adele C Green; Jan Nico Bouwes Bavinck; Ann Perry; Steven Spencer; Judy R Rees; Leila A Mott; Michael Pawlita Journal: J Natl Cancer Inst Date: 2006-03-15 Impact factor: 13.506
Authors: Linda Struijk; Jan Nico Bouwes Bavinck; Patrick Wanningen; Els van der Meijden; Rudi G J Westendorp; Jan Ter Schegget; Mariet C W Feltkamp Journal: J Invest Dermatol Date: 2003-12 Impact factor: 8.551
Authors: Mariet C W Feltkamp; René Broer; Franca M di Summa; Linda Struijk; Els van der Meijden; Bert P J Verlaan; Rudi G J Westendorp; Jan ter Schegget; Willy J M Spaan; Jan Nico Bouwes Bavinck Journal: Cancer Res Date: 2003-05-15 Impact factor: 12.701
Authors: Michelle R Iannacone; Tarik Gheit; Tim Waterboer; Anna R Giuliano; Jane L Messina; Neil A Fenske; Basil S Cherpelis; Vernon K Sondak; Richard G Roetzheim; Sandra Ferrer-Gil; Kristina M Michael; Sandrine McKay-Chopin; Michael Pawlita; Massimo Tommasino; Dana E Rollison Journal: J Invest Dermatol Date: 2013-01-10 Impact factor: 8.551
Authors: Shalaka S Hampras; Rhianna A Reed; Spencer Bezalel; Michael Cameron; Basil Cherpelis; Neil Fenske; Vernon K Sondak; Jane Messina; Massimo Tommasino; Tarik Gheit; Dana E Rollison Journal: J Skin Cancer Date: 2016-11-07
Authors: Rossybelle P Amorrortu; Yayi Zhao; Neil A Fenske; Basil S Cherpelis; Jane L Messina; Anna R Giuliano; Vernon K Sondak; Michael J Schell; Sandrine Mckay-Chopin; Tarik Gheit; Tim Waterboer; Massimo Tommasino; Dana E Rollison Journal: J Infect Dis Date: 2022-09-28 Impact factor: 7.759
Authors: P Di Bonito; L Galati; A Focà; M Brambilla; C Bisaglia; G Bonanno Ferraro; P Mancini; M Iaconelli; C Veneri; G La Rosa Journal: J Appl Microbiol Date: 2019-07-12 Impact factor: 3.772
Authors: Yayi Zhao; Rossybelle P Amorrortu; Neil A Fenske; Basil Cherpelis; Jane L Messina; Vernon K Sondak; Anna R Giuliano; Michael J Schell; Tim Waterboer; Michael Pawlita; Sandrine McKay-Chopin; Tarik Gheit; Massimo Tommasino; Dana E Rollison Journal: Int J Cancer Date: 2020-09-07 Impact factor: 7.396